Similar results were observed for HIV-tuberculosis patients receiving antiretroviral therapy concurrent with tuberculosis treatment, highlighting the relationship among M. tuberculosis, immune activation and circulating T cell CD8+/CD38+ cells [6], [26]. The gene discussed is CD38; the disease is tuberculosis.